Dissent: an alternative interpretation of MAST-I

The Lancet

Volumn 346, Issue 8989, 1995, Pages 1515-

  Tognoni, G ^a   Roncaglioni, M C ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; STREPTOKINASE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028892635     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92050-1     Document Type: Article

References (3)

1. Termination of trial of streptokinase in severe acute ischaemic stroke
2. Trials of streptokinase in severe acute ischaemic stroke
3. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke